Combinatorial chemistry as a tool for drug discovery

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Chemical Biology

Background:

• The integration of synthesis and biological assays is fundamental to the combinatorial approach in drug discovery.
• Traditional medicinal chemistry analogue programs have been the standard for drug development.
• The question of whether combinatorial chemistry can deliver real medicines remains a key consideration.

Purpose of the Study:

• To evaluate the effectiveness of combinatorial chemistry in drug discovery.
• To assess the current status and future potential of combinatorial approaches in medicinal chemistry.
• To explore the integration of synthesis and biological assays in drug development.

Main Methods:

• Screening of smaller directed combinatorial libraries.
• Analysis of results from Tables 3.1 to 3.8.
• Investigation of libraries screened against multiple targets.
• Assessment of the feasibility of handling larger non-oligomeric libraries.

Main Results:

• Smaller directed combinatorial libraries have yielded results comparable to traditional medicinal chemistry programs.
• Active leads have been identified from screening single libraries against multiple targets.
• The capacity to handle larger combinatorial libraries and the required chemistry is advancing.
• The adaptation of combinatorial approaches to address drug properties like toxicity and bioavailability is under investigation.

Conclusions:

• Combinatorial chemistry is a valuable tool for medicinal chemists, offering new avenues for drug development.
• While marketed drugs from combinatorial methods are not yet available, the field shows significant optimistic potential.
• Further research is needed to fully adapt combinatorial approaches to all aspects of successful pharmaceutical development.